HTLV-1 and Innate Immunity
Open Access
Abstract
Innate immunity plays a critical role in the host response to a viral infection. The innate response has two main functions. First, it triggers effector mechanisms that restrict the infection. Second, it primes development of the adaptive response, which completes the elimination of the pathogen or of infected cells. In vivo, HTLV-1 infects T lymphocytes that participate in adaptive immunity but also monocytes and dendritic cells that are major players in innate immunity. Herein, we will review the interplay between HTLV-1 and innate immunity. Particular emphasis is put on HTLV-1-induced alteration of type-I interferon (IFN-I) function. In vitro, the viral Tax protein plays a significant role in the alteration of IFN synthesis and signaling. Despite this, IFN-I/AZT treatment of Adult T‑cell Leukemia/Lymphoma (ATLL) patients leads to complete remission. We will discuss a model in which exogenous IFN-I could act both on the microenvironment of the T-cells to protect them from infection, and also on infected cells when combined with other drugs that lead to Tax down-regulation/degradation.Keywords
This publication has 91 references indexed in Scilit:
- Human T Cell Leukemia Virus Type 1 Tax Inhibits Innate Antiviral Signaling via NF-κB-Dependent Induction of SOCS1Journal of Virology, 2011
- Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemiaJournal of Experimental Medicine, 2010
- BST-2/tetherin: a new component of the innate immune response to enveloped virusesTrends in Microbiology, 2010
- Human T Cell Lymphotropic Virus 1 Manipulates Interferon Regulatory Signals by Controlling the TAK1-IRF3 and IRF4 PathwaysJournal of Biological Chemistry, 2010
- DC-SIGN Mediates Cell-Free Infection and Transmission of Human T-Cell Lymphotropic Virus Type 1 by Dendritic CellsJournal of Virology, 2009
- Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological diseaseClinical and Experimental Immunology, 2009
- Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by TetherinJournal of Virology, 2009
- Human T-cell leukemia virus type 1 blunts signaling by interferon alphaVirology, 2008
- Human T-Cell Leukemia Virus Type 1 (HTLV-1) p12IDown-Modulates ICAM-1 and -2 and Reduces Adherence of Natural Killer Cells, Thereby Protecting HTLV-1-Infected Primary CD4+T Cells from Autologous Natural Killer Cell-Mediated Cytotoxicity despite the Reduction of Major Histocompatibility Complex Class I Molecules on Infected CellsJournal of Virology, 2007
- Peripheral Blood Mononuclear Cells from Individuals Infected with Human T-Cell Lymphotropic Virus Type 1 Have a Reduced Capacity To Respond to Recall AntigensClinical and Vaccine Immunology, 2006